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Pancreatic Organotherapy for Diabetes, 1889-1921
ROBERT TATTERSALL*
Introduction
The isolation of insulin by Banting and Best in 1921 and its rapid commercial
exploitation revolutionized the treatment of diabetes. The story, frequently told as a
romance ofmedicine, is that a young orthopaedic surgeon, Frederick Banting, went to the
local Professor of Physiology, J J R Macleod, asking for facilities to try to isolate the
internal secretion of the pancreas. Macleod was sceptical but provided a lab, dogs and a
student assistant to measure blood sugar. After only three months, Banting and Charles
Best isolated a potent anti-diabetic substance which was first used on a human diabetic in
January 1922. Controversy followed when Banting and Macleod, not Banting and Best,
were awarded the 1923 Nobel Prize. Much has been written about the events in Toronto
in 1921-1922l as well as about the priority disputes which followed.2
Two editorials in the Lancet in 1923 questioned why this discovery had taken so long.3
The seductively simple critique ran as follows: in 1869, Paul Langerhans described his
eponymous islands, in 1889 Oskar Minkowski produced severe diabetes in dogs by
pancreatectomy, in 1891 George Murray cured myxoedema by injections of thyroid
extract and in 1893 Gustave-Edouard Laguesse suggested that the islands ofLangerhans
produced "an endocrine secretion" which controlled carbohydrate metabolism. How
could it have taken thirty years for therapeutics to exploit the physiological suggestion?
The origins ofthe hormone concept and the history oforganotherapy in general have been
explored in detail by Merriley Borell.4 Her work focuses on the role of physiologists,
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whereas in the present paper I concentrate on the perspective of clinicians and examine
their attempts to treat diabetes between 1889 and 1921.
The announcement that extirpation ofthe pancreas caused diabetes was received with
great surprise because between 1850 and 1889 diabetes was held to be a disease of the
liver, largely as aresult ofthe work ofClaude Bernard. After Murray's report in 1891 that
myxoedema could be cured by thyroid extract, it was widely believed that the pancreas
controlled carbohydrate metabolism by producing an internal secretion and, at least to
physiologists, the likely source of this material was the internal vascular islets. In the
decade after 1889 numerous attempts were made by clinicians to treat diabetes by feeding
or injecting extracts of the pancreas, and their evident failure led them to doubt whether
diabetes really was due to lack of an internal secretion. Myxoedema and Addison's
disease, known or suspected to be due to absence ofan internal secretion, were associated
with shrunken glands but, in an age still dominated by morbid anatomy, the failure to find
consistent changes in the pancreas of diabetics was regarded as evidence against the
internal secretion theory. Some of the clinical scepticism was prompted by the disrepute
into which organotherapy fell as a result of the work of C E Brown-Sequard and the
commercialization oforgan extracts. Also clinicians recognized many possible causes of
diabetes including pancreatic, hepatic, neurogenic and other forms. In fact, because ofthe
difficulty of measuring blood sugar before 1915, diabetes was usually equated with
glycosuria and when testing the effect of organotherapeutic or other preparations
clinicians used urine glucose and volume as the endpoints. This practice was frequently
criticized by physiologists who advocated blood sugar or indices oftotal metabolism such
as the dextrose/nitrogen ratio. Many physiologists and clinicians continued to hold that
the pancreas (and/or particularly the islets of Langerhans) must produce an antidiabetic
substance, but they had become so discouraged that between 1915 and 1920 only four or
five individuals were actively working on the problem.
"One ofthe most Inscrutable ofDiseases":5
Ideas about the Aetiology ofDiabetes to 1889
Diabetes, as a clinical disorder, has a continuous history in medical texts. One of the
first, and most elegant, clinical descriptions is that of Aretaeus who practised in
Cappadocia, probably around 120 AD. He described it as:
A wonderful affection not very frequent among men, being a melting down of the flesh and limbs
into urine .... The kidneys andbladder, the usual passageways offluid, do not cease emitting urine,
and the outpouring is profuse and without limit. It isjust as though the aqueducts were opened wide.
The development ofthis disease is gradual, but short will be the life ofthe man in whom the disease
is fully developed. Emaciation proceeds quickly and death occurs rapidly .. .6
The sweet taste ofdiabetic urine was reported in the middle ofthe seventeenth century
by Thomas Willis (1621-1675), and in 1776 Matthew Dobson evaporated the urine of a
5 The Guy's physician F W Pavy (see note 17 6 J A Reed, 'Aretaeus, the Cappadocian',
below) used this phrase in most ofhis published Diabetes, 1954, 3: 419-21.
works on diabetes.
289Robert Tattersall
diabetic patient leaving a residue which not only smelled and tasted like sugar but could
be fermented.7
In the middle of the nineteenth century tasting the urine was superseded by the
invention of chemical tests such as Trommer's (1841), Moore's (1844), and Fehling's
(1849) which detected reducing substances in the urine.8 It was soon clear that the copper
solution, which formed the basis of these tests, could be reduced by substances in the
urine other than glucose. Also some people who were not ill but whose urine was tested
(usually for life insurance purposes) showed a reducing substance which by fermenting
was proved to be sugar. This did not change clinicians' picture of the disease and most,
like a Dr Daniel Hooper writing to the Lancet in 1873, dismissed the reduction of
Fehling's soluion by the urine of apparently healthy people as "mere glycosuria", not true
diabetes.9 True diabetes it was agreed was a fatal disease characterized by polyuria, thirst,
progressive weight loss and debility. A typical description is that of Bristowe, who in
1882 wrote:
The prominent features of this disease are: the excretion of an excessive quantity of urine loaded
with glucose, intense thirst, voracious appetite together with progressive emaciation and debility,
followed after a longer or shorter time by death . .. for the most part the patient succumbs in one
to three years.'0
True diabetes could be distinguished by the persistence of glycosuria, its degree and its
association with polyuria."I
By 1850 ideas about the seat of the disease centred on the liver, mainly as a result of
the work of the French physiologist Claude Bernard (1813-1878). When Bernard began
his work in 1843, the prevailing view was that sugar could be synthesized only by plants
and that when eaten by animals it was either burned in the lungs or destroyed in the
general circulation. It was also held that the blood contained sugar only after meals or in
pathological states such as diabetes. Between 1846 and 184812 Bernard reported that
sugarI3 was present in the blood of normal animals, even when starved, a finding which
he at first found so astonishing that he doubted the specificity of his analytical method.
He also reported that the concentration of sugar was higher in the hepatic than in the
portal vein and that sugar was present in "enormous quantities" in the liver but not in any
other organ. Bernard's hypothesis was that sugar absorbed from the intestine was
converted in the liver into glycogen.14 The liver then acted, in Bernard's words, as a
7 Thomas Willis in Practice ofphysick, being 12 M D Grmek, 'First steps in Claude Bernard's
the whole works ofthat renowned andfamous discovery of the glycogenic function of the liver', J.
physician, London, 1684, p. 76. Hist. Biol., 1968, 1: 141-54.
8 S J Reiser, Medicine and the reign of 13 In the latter half of the nineteenth century it
technology-chemical signposts ofdisease and the was well known that the reducing substance in
birth ofthe diagnostic laboratory, Cambridge diabetic urine was dextrose or grape sugar but until
University Press, 1978, pp. 122-44. the 1920s it was described simply as sugar and I
9 D Hooper, 'On Fehling's test' and the shall use this terminology.
significance of sugar in the urine', Lancet, 1873, i: 14 Glycogen was discovered independently by
360. Victor Hensen. See R Porep, 'The priority dispute
10 J S Bristowe, A treatise on the theory and between Claude Bernard and Victor Hensen about
practice ofmedicine, London, Smith, Elder, 1882, the discovery ofglycogen', Medizinische
4th ed., p. 836. Monatsschrift, 1971, 25: 314-21.
F Taylor, A manual ofthepractice ofmedicine,
London, J & A Churchill, 1891, 2nd ed., p. 779.
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syringe which constantly replenished the level ofsugar in the blood during fasting.'5 The
crux of Bernard's theory was his claim that there was always more sugar in the hepatic
than the portal vein. In fact he found a complete absence of sugar in the portal vein but
concentrations of 700-9000 mg% in the hepatic.16
In England the main opponent of Bernard's glycogenic theory was the Guy's Hospital
physician Frederick William Pavy (1829-1911), described in his obituary as "the leading
authority on diabetes" for more than a generation.'7 Pavy regarded the breakdown of
glycogen as "simply a post-mortem fact", denied that there was a leak point (i.e. renal
threshold) below which glucose did not appear in the urine, and strenuously maintained
that the liver acted as a barrier to the entry of carbohydrates into the system. Pavy was
treated with extraordinary deference by his contemporaries, but towards the end ofhis life
his views were apparently regarded as archaic and, according to an epitaph, "he was
gradually forced, not so much by the results of others, which he seldom read, as by his
own experiments, to give up his original position bit by bit".18
Bernard's views were generally accepted by physiologists, and in 1879 Michael Foster,
later Professor ofPhysiology at Cambridge, summed up what was known about the cause
ofdiabetes:
Sugar in the urine means an excess ofsugar in the blood. How in natural diabetes that excess arises,
we have at present no facts to show: but it is extremely probable that the sources ofthe excess may
be various and hence that several distinct varieties of diabetes may exist ... In many cases, the
sugar continues to be discharged, even though the diet be perfectly free from carbohydrates; and in
many other cases the sugar in the urine is far in excess ofthat taken as food. In these cases the sugar
must have a non-amylaceous source.19
To those who accepted Bernard's hypothesis such as Thomas Lauder Brunton,20 the
excess of sugar might arise in three ways: (1) failure of the liver to form glycogen, (2)
excessive breakdown of glycogen, or (3) diminished combustion of sugar, mainly in the
muscles.21 Failure of nervous control of the liver was the preferred mechanism. Claude
Bernard had reported that glycosuria could be caused by lesions in the 4th ventricle
15 F L Holmes, Claude Bernard and animal
chemistry, Cambridge, Mass., Harvard University
Press, 1974, p. 424.
16 J M D Olmsted, Claude Bernard:
physiologist, London, Cassell, 1939.
17 FW Pavy, obituary, Br med. J., 1911, ii:
777-8.
18 Editorial, 'Pavy and Diabetes', J. Amer. med.
Ass., 1913, 60: 1159-60. The editorial writer quoted
Sir William Gull's satirical question, "What sin has
Pavy committed or his fathers before him, that he
should be condemned to spend his whole life
seeking for the cure of an incurable disease?" That
there was bad blood between Gull and Pavy, both
physicians at Guy's Hospital, is shown by the fact
that they were reprimanded in 1881 by the Royal
College ofPhysicians for becoming embroiled in
professional disputes in public. See M Jeanne
Peterson, The medicalprofession in mid-Victorian
London, Berkeley and Los Angeles, University of
California Press, 1978, p. 255.
19 M Foster, A textbook ofphysiology, London,
Macmillan, 1879, 3rd ed., p. 390-3.
20 T Lauder Brunton (1844-1916), later Sir
Thomas Lauder Brunton, was at the turn of the
century the most widely known consulting physician
in London. After graduating at Edinburgh he spent
three years on the Continent, after which "he was
probably better acquainted with modern methods of
physiology and pharmacology than anyone else in
this country" (Sir Edward Sharpey-Schafer, History
ofthephysiological Society ... 1876-1926, London,
Cambridge University Press, 1927, p. 31). Brunton,
like Pavy and Michael Foster, was a founder
member ofthe Physiological Society.
21 T Lauder Brunton, 'Lectures on the pathology
and treatment ofdiabetes mellitus', Lecture I,
Br med. J., 1874,i: 1-3, p. 2.
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(piqiure diabetes)22 and, because of the proximity of the vasomotor and a postulated
diabetic centre in the medulla, it seemed to him that the excessive conversion ofglycogen
into sugar was the result of a vasomotor disturbance in the liver.23 Another possible
mechanism was diminished combustion of sugar. Brunton postulated that diabetes might
arise from reduced combustion in the muscles as a result of insufficiency of a ferment, a
change in the sugar making it resistant,24 or diminished circulation through the muscles.
The use ofdrugs in diabetes was disdained by experts in the 1870s and 1880s, although
every year there were reports that various nostrums were particularly effective in the
hands ofsuch-and-such a doctor. William Osler, a noted therapeutic nihilist, is famous for
his comment that only opium stood the test ofexperience as a remedy capable oflimiting
the progress of the disease.25 In 1874 Brunton26 suggested that, inter alia, treatment
should exclude all articles offood containing starch or sugar, reduce the circulation in the
liverby hot baths and warm clothing, and lessen the excitability ofthe hepatic nerves with
morphine or codeine.27
After the introduction of organotherapy Brunton claimed credit for having been the
first to use animal extracts.28 Reasoning that since the muscles were the site of sugar
breakdown, they were likely to contain "the necessary ferment", he gave diabetic patients
raw meat and also made a glycerine extract of muscle for subcutaneous injection.29 His
one test case was a failure. I Burney Yeo wrote that he had used raw meat in 1873 on the
basis of reports that "a medical man in Constantinople" had obtained a great reputation
forcuring diabetes with it. Yeo tested it on two patients without notable results and mused
that its failure might have been due to the type or preparation of meat. After all, he
commented, "There is raw meat and raw meat. The dry blanched veal ofthis country must
be a very different thing from the darkjuicy veal ofthe Continent".30
22 C Bernard, LeVons dephysiologie, Paris, J-B
Bailliere, 1855, p. 315, quoted by D A Pyke in
'Diabetes: the genetic connections', Diabetologia,
1979, 17: 333-243. The nervous origin ofdiabetes
greatly preoccupied physicians in the period
1890-1914 although they knew that glycosuria
following piqfire lasted less than 24 hours and could
not be induced if the liver was depleted ofglycogen.
As an example ofthe concern that strain caused
diabetes, J J R Macleod wrote in 1914, "Diabetes is
common in locomotive engineers and the captains of
ocean liners, that is to say, in men who in the
performance of their daily duties are frequently put
under a severe nerve strain." ('Recent work on the
physiologic pathology ofglycosuria', J. Am. med.
Ass., 1914, 113: 1226).
23 T Lauder Brunton, 'Lectures on the pathology
and treatment of-diabetes mellitus, Lecture II', Br
med. J., 1874, i: 39-41.
24 Bernard had already considered this
possibility. He obtained sugar from the urine of
diabetics and injected it intravenously into animals.
It disappeared in exactly the same way as pure grape
sugar without producing glycosuria. Holmes, op.
cit., note 15 above, p. 410.
25 W M Osler, Theprinciples andpractice of
medicine, New York, D Appleton, 1892, 1st ed., p.
299.
26 T Lauder Brunton, 'The pathology and
treatment ofdiabetes mellitus', Lecture III, Br med.
J., 1874, i: 221-3, p. 223.
27 It was widely believed that diabetics could
tolerate large doses ofopium without becoming
addicted. Thus, in Bristowe, op. cit., note 10 above,
p. 842, "Diabetic patients are said to be little
susceptible to the influence ofopium and may
therefore take it with safety in comparatively large
quantities".
28 T Lauder Brunton, 'Organs of animals in the
treatment ofdisease', Lancet, 1894, i: 1096-7, "I
believe the attempts I made in 1873 to treat diabetes
were the first in which cure of a disease was sought
to be effected by the administration of ferments
derived from solid organs and not from glands
connected with the alimentary canal".
29 Brunton, op. cit., note 26 above, p. 223.
30 'Raw meat in diabetes', Lancet, 1894, i: 1160.
Isaac Burney Yeo (1835-1914) became Professor of
Clinical Therapeutics at King's College Hospital in
1885 and Professor of Medicine in 1896.
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Pancreatic Diabetes
In early times the pancreas was regarded as a mechanical packing to support the
stomach and branches ofthe aorta.31 A connection with diabetes was not suggested until
the 1870s when the French physician Apollinaire Bouchardat (1806-1886) pointed out
that lesions of the pancreas were sometimes found in diabetic post-mortems.32 He
apparently tried to pancreatectomize animals butfailed because his surgery was too crude.
This experiment was done in April 1889 when Oskar Minkowski (1858-1931), First
Assistant to Professor Bernhard Naunyn in the University of Strassburg, met Josef von
Mering (1849-1908), the discoverer of"phloridzin diabetes",33 in the library where they
discussed the latter's research in patients with pancreatic (exocrine) insufficiency. In this
idealized account, recalled thirty years later, Minkowski asked whether his colleague had
done any experiments to prove that free fatty acids in the diet were beneficial; von Mering
answered, "No, because even ligating the pancreatic duct does not completely exclude
digestive enzymes". "Well, then", said Minkowski, "remove the whole pancreas". A
spare dog was available, and the same afternoon
von Mering and I removed the gland in toto . . . the animal withstood the operation surprisingly
well, and we thought we would use it for the absorption experiments as soon as the wound healed.
We did not think ofdiabetes; hence, we did not test the urine for glucose".34
Minkowski pancreatectomized three more dogs; the first two died, but the third survived
and, from the second day after the operation, had persistent diabetes. Minkowski
presented his results35 at the First International Congress of Physiology in Basle in
September 1889, and the same month the Lancet announced that
Doctors von Mering and 0 Minkowski report a large number of experiments from their lab at
Strassburg, all showing that extirpation ofthe pancreas results in true diabetes with all its ordinary
symptoms. A dog whose pancreas had been removed secreted after 48 hours' fasting from five to
six percent ofsugar in his urine. Anotherdog weighing 15 lbs secreted under an exclusive meat diet
two pints of urine daily with 6-8% of sugar ... The percentage of sugar in the blood was likewise
much increased. Glycogen at the same time disappeared altogether.36
31 H D Rolleston, The endocrine organs in health
anddisease, Oxford University Press, 1936, p. 422.
32 E P Joslin, 'Apollinaire Bouchardat',
Diabetes, 1952, 1: 490-1.
33 Phloridzin (sometimes spelt phlorizin) is a
glucoside from the root-bark ofthe cherry, apple,
pear and plum. Its glycosuric effect was discovered
by and intensively investigated by von Mehring.
What impressed him and other investigators was
"the absence ofthe hyperglycaemia which
accompanies every other form ofintense glycosuria"
(F M Allen, Studies concerning glycosuria and
diabetes, Boston, W M Leonard, 1913, p. 620).
Much effort was expended to find the site ofaction
ofphloridzin and this was eventually established as
the kidneys. It is now known to be a potent inhibitor
of renal glucose transport.
34 0 Minkowski, 'Die Lehre vom Pankreas-
Diabetes in ihrer geschichtlichen Entwicklung',
Munch. Wed. Woch., 1929, 76: 311-15 (reprinted as
'Historical development of the theory ofpancreatic
diabetes' in Diabetes, 1989, 38: 1-6). In this article
Minkowski suggested that "the discovery of
pancreatic diabetes tended to validate the view that a
piece of scientific research may actually profit from
total ignorance on the part of the investigators of
any prior attempts and results".
35 Throughout I have referred to Minkowski as
the discoverer ofpancreatic diabetes because,
although he assisted at the first operation, von
Mering played no further active role. Minkowski
wrote theirjoint papers and put their names in
alphabetical order. For further discussion see B A
Houssay, 'The discovery ofpancreatic diabetes: the
role ofOscar Minkowski', Diabetes, 1952, 1:
112-16.
36 Lancet, 1889, ii: 552.
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The announcement that pancreatectomy caused diabetes surprised many but it was
widely accepted within two or three years. In November 1890, the Lancet reported37 the
experiments of Hedon,38 who had excised the pancreas in 22 dogs, all of which then
passed sugar and developed diabetic-like symptoms. In his Bradshaw Lecture of 1890,
Robert Saundby pointed out that ever since Lancereaux drew attention to the frequency of
pancreatic atrophy in diabetes and associated it with diabete maigre39 "the changes in this
organ have been interesting, but they are especially so since the experiments of
Minkowski, Lepine and others". He also noted that the pancreas was often rather
superficially examined by pathologists but agreed with Lancereaux that it was shrunken in
all cases oftypical wasting diabetes.40
In their original paper von Mering and Minkowski emphasized that they had not
damaged the solar plexus but others continued to wonder whether injury to the abdominal
sympathetic nerves was the real cause of diabetes after pancreatectomy. This hypothesis
was floated by the Lancet in October 1891 reporting a meeting at the Academie de
Medecine in Paris where Lancereaux had shown a dog which survived
hemipancreatectomy in good health but developed diabetes after the other half was
removed. In the discussion which followed, the Lancet reported that various and
conflicting views were expressed; some held that diabetes was of three varieties-
pancreatic, gouty and traumatic, while others asserted that the gouty variety should not be
called diabetes at all as the glycosuria was merely a symptom ofanother condition.41 The
same lack of agreement was also present in England; at a meeting of the Royal Medical
and Chirurgical Society on 26 January 1892, Dr Tylden criticized the pancreatic theory
mainly because lesions were not consistently found in the pancreas ofdiabetic patients.42
The persistence of the neurogenic theory, also supported by Tylden, was shown by the
comments ofDrRolleston,43 who suggested that any severe disease ofthe pancreas might
reflexly stimulate the medulla oblongata so as to produce diabetes by increased
metabolism ofthe liver. On the otherhand DrBradforde declared that the best established
fact in experimental pathology was that removal of the pancreas caused diabetes. It was
idle, he believed, to suggest that diabetes was caused by damage to other organs in the
vicinity since physiologists had repeatedly damaged them without producing glycosuria.
37Lancet, 1890, fi: 1002.
38 From 1890 to 1913 Edouard H&lon
(1863-1933) carried out transplantation and
parabiotic experiments in dogs which conclusively
showed that canine diabetes could be cured by a
subcutaneous pancreas implant or transfusion of
blood from a healthy dog.
39 E Lancereaux, 'Notes et r6flexions, A propos
de deux cas de diabete sucre avec alt6ration du
pancr6as', Bull. Acad. Mid., 1877, 6: 1215-40.
Etienne Lancereaux was President of the French
Academy ofMedicine. As well as being
remembered for his description ofthe thin diabetic
('Le diabete maigre: ses sympt6mes, son evolution,
son prognostie and son traitement', Un Mid. Paris,
1880, 20: 205-11), he was the teacher ofNicolas
Paulesco, the Roumanian, who is often considered
the co-discoverer of insulin.
40 R Saundby, 'The Bradshaw Lecture on the
morbid anatomy ofdiabetes mellitus', Lancet, 1890,
ii: 381-6. Robert Saundby (1849-1918) started life
as a tea planter and in 1885,became a full physician
at Birmingham General Hospital. He wrote a review
ofdiabetes for the Medical Annual for several years
in the 1890s.
41 'Diabetes and the pancreas', Lancet, 1891, ii:
1001.
42 Lancet, 1892, i: 254; Henry John Tylden
(1867-1902) was a promising young pathologist
who died of typhoid aged 35.
43 Presumably Dr H D Rolleston, who later
became Sir Humphry Davy Rolleston, Regius
Professor of Physic at Cambridge University. He
wrote a textbook ofendocrinology. See note 31
above.
44 John Rose Bradford (1863-1935), later
knighted.
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A Substance Lacking: the Doctrine ofInternal Secretions
In 1922 Swale Vincent, Professor ofPhysiology at the Middlesex Hospital, claimed that
the concept of internal secretions was introduced jointly by Claude Bernard and Brown-
Sequard.4s In fact, neither thought ofthem as specific chemical messengers; Bernard used
the term to distinguish between the bile-producing (external secretory) and glycogenic
(internal secretory) functions of the liver and also stated that other organs such as the
spleen, thyroid, supra-renal capsules and lympathic glands produced an internal secretion.46
His contemporary Brown-Sequard claimed priority from an address before the Medical
Faculty of Paris in 1869 in which he suggested that all glands, with or without ducts,
"supply to the blood substances which are useful or essential and the lack of which may
producephysiological signs".47
In the same year that Minkowski announced his results, there occurred an event which
Gley later claimed had caused "the idea of internal secretion to take possession of the
general imagination and gave the question a totally different aspect".48 This was a
presentation by the 72-year-old physiologist and physician Charles Edouard Brown-
Sequard49 at a meeting of the Societ6 de Biologie in Paris on 1 June 1889. Starting from
the premise that "Seminal losses, from any cause, produce a mental and physical debility
which is in proportion to their frequency", he argued that the testes produced a
"dynamogenic" substance which might be extracted and injected into aging and debilitated
animals to restore their strength. He prepared testicular fluid from animals and injected
himself with it almost every day for two weeks, with what the British Medical Journal
sarcastically described as results which appeared to him to warrant an immediate
communication.50 He claimed to be rejuvenated and have the same vigour as thirty years
before with more regular bowels and an increase in the length of hisjet of urine.51 These
observations, albeit made by a distinguished physiologist who was well known in England,
were greeted with incredulity in the English medical press and, according to the British
Medical Journal, his statements recalled the wild imaginings of medieval philosophers in
search of an elixir vitae. It is said that Brown-Sequard's theories were at once accepted in
45 S Vincent, The Arris and Gale lecture, 'A
critical examination ofcurrent views on internal
secretion', Lancet, 1922, ii: 313-20, p. 313.
46 Claude Bernard, Lefons sur lesproprietes
physiologiques et les alterations pathologiques des
liquides de l'organisme, Paris, Balliere, 1859.
47 Cited by Artur Biedl in The internal secretory
organs: theirphysiology andpathology, London,
John Bale, Sons and Danielsson, 1913, p. 4. Biedl
(1869-1933) was a pioneer in clinical and
experimental endocrinology. His monograph on
internal secretions was first published in 1903 and
by 1910 had expanded into two large volumes.
48 E Gley, 'The theory ofinternal secretion: its
history and development', The Practitioner, 1915,
Jan-June: 5-8, p. 5. This is a lecture which Eugene
Gley (1857-1930), Professor ofPhysiology at the
College de France, gave at the International
Congress ofMedicine in London in 1913. A Brown-S6quard (1817-1894) was born in
Mauritius, the posthumous son of an Irish American.
Since Mauritius had been annexed by England in
1814 he was a francophone and an English citizen.
By 1856 he was already famous for his description
ofthe sensory decussation ofthe spinal nerves and
discovery ofvasomotor nerves. In 1860 he became
physician to the National Hospital for the Paralysed
and Epileptics (Queen Square) and in 1878
succeeded Bernard in the Chair ofMedicine at the
College de France. For a sympathetic view of this
remarkable man, see J M D Olmsted, Charles-
tdouardBrown-Sequard: a nineteenth-century
neurologist andendocrinologist, Baltimore, The
Johns Hopkins Press, 1946, and M J Aminoff,
Brown-Sequard: a visionary ofscience, New York,
Raven Press, 1993.
50 Aminoff, ibid., pp. 159-73; 'The pentacle of
rejuvenescence', Br med. J., 1889, i: 1416.
5S Brown-Sequard was a compulsive self-
experimenter who for years kept records ofhis own
physiological functions. He was also an
extraordinarily vigorous man whose "excessive zeal
for work often led him to spend as much as 20 hours
a day on his experiments", obituary, Lancet, 1894, i:
975-7.
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France and, to some extent in England, although German physiologists and clinicians were
extremely sceptical.52 In March 1891 Brown-Sequard suggested that his assistant
d'Arsonval53 should make extracts of liver, spleen, kidney, suprarenal capsules, pancreas,
thyroid, lungs, salivary glands, brain and spinal cord, because:
I say now merely that all glands with an external secretion have, at the same time, like the testicles,
an internal secretion. The kidneys, the salivary glands, and the pancreas are not merely organs of
elimination. They are, like the thyroid, the spleen etc., organs giving to the blood important principles
either in a direct manner or by resorption, after their external secretion.
The pancreas was of particular interest because, as Brown-Sequard noted, "When the
pancreas has been suppressed (ablation, ligature of its veins etc.) there is diabetes" and he
wondered whether this would be cured if people were given daily injections of pancreas
extract from a healthy animal.54
The emerging doctrine of internal secretions and the potential of organ extracts55 were
given powerful support by the dramatic effects of thyroid extracts in the treatment of
myxoedema first reported in 1891 and repeatedly confirmed within a year. Until the middle
of the nineteenth century practitioners agreed that the function of the thyroid was not yet
known but, in the mid-1880s, the Swiss surgeon Theodor Kocher56 reported that total (but
notpartial) thyroidectomy created acondition analogous to myxoedema and VictorHorsley
reported that he had produced an animal model ofmyxoedema by removing the thyroid in
a monkey.57 These reports were soon accepted and in February 1891 Dr George Murray
showed a 46-year-old woman with florid myxoedema at a meeting of the Northumberland
and Durham Medical Society.58 He described how he intended to treat her with thyroid
extract and his reasons for expecting it to work. Treatment began in April 1891 when 25
minims of glycerine extract of thyroid from a freshly killed sheep was given
hypodermically twice a week. She gradually improved and Murray presented the case atthe
annual meeting of the British Medical Association in Bournemouth in 1891 and in the
British Medical Journal in October 1891. Others soon showed that thyroid extract by
mouth was equally effective and Murray's patient switched to 10 minims orally six nights
a week and remained well until 1919, when she died of cardiac failure aged 74.59 In 1893
the British Medical Journal declared that "In the treatment of myxoedema by thyroid
extract, scientific medicine has achieved one of the most striking and significant triumphs
which have ever been won in the field of practice".60 The pharmacologist Arthur Cushny
52 Biedl, op. cit., note 47 above, pp. 4-5.
53 Arsene d'Arsonval (1851-1940) succeeded
Brown-Sequard as Professor at the College de
France.
54 Olmstead, op. cit., note 49 above, p. 216-17.
55 The therapeutic movement of treatment by
animal extracts was most commonly known as
organotherapy. In 1895 Landouzy introduced the
term "opotherapy" ('6pos=juice) and others were
also used, including sequardotherapy, histotherapy
and zoopotherapy. See H Batty Shaw,
Organotherapy or treatment by means of
preparations ofvarious organs, London, Cassell,
1905, p. 2.
56 An interesting discussion of Kocher's
research is found in Thomas Schlich, 'Changing
disease identities: cretinism, politics and surgery
(1844-1892)', Med. Hist., 1994, 38: 421-43.
57 V A H Horsley, 'A recent specimen of
artificial myxoedema in a monkey', Lancet, 1884, ii:
827.
58 G R Murray, 'Note on the treatment of
myxoedema by hypodermic injections of an extract
of the thyroid gland of a sheep', Br med. J., 1891, i:
796-7. George Redmayne Murray (1865-1939) was
a pathologist in Durham at the time but in 1908
became Professor ofMedicine in Manchester.
59 G R Murray, 'The life-history of the first case
ofmyxoedema treated by thyroid extract', Br med.
J., 1920, i: 359-60.
60 'Thyroid extract in myxoedema', Br med. J.,
1893, i: 252.
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later described it as "one of the most satisfactory examples of rational therapeutic
progress".61
By 1893 the British Medical Journal had overcome its incredulity sufficiently to publish
two papers by Brown-Sequard; there was no doubt, he stated, that the pancreas had an
internal secretion which was even more important than its external one, and he
recommended the simultaneous use of orchitic and pancreatic liquid in all cases of
glycosuria. Immodestly, he concluded that "the great movement in therapeutics as regards
the organic liquid extracts has origin in the experiments I made on myself in 1889,
experiments which were at first so completely misunderstood".62 In an accompanying
editorial theBritish MedicalJournal acknowledged that "though manyjeered at him as the
discoverer of the secret of perpetual youth", there was perhaps something in it and that
since the success of thyroid extract, this belief had strengthened.63 The writer of the
editorial nevertheless worriedthatthere mightbe "an epidemic ofuniversal injections", and
this was what happened since, by the time Brown-Sequard made his last report to the
Academy ofSciences in 1893, his orchitic fluid had been very widely tested and appeared
to alleviate, if not cure, most known ailments.64 For example, 314 of 405 cases of
locomotor ataxia (tabes) had benefited, four ofevery five cases ofpulmonary tuberculosis
were cured and diabetes was alleviated. Brown-Sequard was careful to warn thathis extract
did not cure but simply strengthened the natural resistance ofthe organism.65 Nevertheless,
he predicted that:
An immense field is open to practitioners who will want to employ liquid extract of diverse tissues
and organs as a therapeutic medium ... Thus, for example, one could administer thyroid liquid in
myxoedema, exothalmic goitre orafterthyroidectomy; in the cases ofAddison's disease, liquid ofthe
supra-renal capsules; in the case of wasting disease, pancreatic liquid; in the cases of leukaemia,
liquid ofthe lymphatic glands, the spleen and the bone marrow.66
Pancreas Feeding and Injecting: 1893-1900
There are well known instances where clinicians recognized in an animal model adisease
they had seen in the wards. In 1881 David Ferrier showed a monkey in which, by ablating
the motor area of the left cerebral hemisphere, he had produced paralysis of the right arm
and leg. Jean-Martin Charcot, recognizing the gait of a hemiplegic patient, exclaimed
"C'est un malade".67 In 1910 when Harvey Cushing saw ahypophysectomized dog which
was listless, fat and asexual he immediately said "Here is Frolich's sexual adiposity".68 In
61 A R Cushny, A textbook ofpharmacology and
therapeutics, Philadelphia and New York, Lea
Brothers, 1899, p. 691. Arthur Cushny (1866-1926)
held the ChairofPharmacology at University College
London from 1905 to 1918 and then the Chair of
Materia Medica in Edinburgh. He was a persistent
critic ofthe unthinking use oforganotherapy.
62 C E Brown-Sequard, 'On a new therapeutic
method consisting of the use oforganic liquids
extracted from glands and other organs', Br med. J.,
1893, i: 1145-7, 1212-14, p. 1213.
63 'Animal extracts as therapeutic agents', Br
med. J., 1893, i: 1279.
64 By the end of 1889 more than 12,000
physicians worldwide were using Brown-Sequard's
fluid, which its inventor supplied without charge,
asking only that the results ofits use be
communicated to him. Olmsted, op. cit., note 49
above, p. 209.
65 Brown-Sequard, op. cit., note 62 above,
p. 1214.
66 This quotation is taken from Borell, 'Origins
E of the hormone concept', op. cit., note 4 above.
67 W F Bynum, "'C'est un malade": animal
models and concepts of human diseases', J. Hist.
Med. Allied Sci., 1990, 45: 397-413.
68 L G Wilson, 'Internal secretions in disease:
The historical relations ofclinical medicine and
scientific physiology', J. Hist. Med. Allied Sci.,
1984, 39: 263-302.
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the same vein physicians tried to identify a clinical variety ofhuman diabetes analogous to
experimental pancreatic diabetes. The most obvious candidate was the acute rapidly fatal
condition seen in young people and, in 1892, Vaughan Harley wrote that:
The signs and symptoms ofdiabetes, eitherdepending upon or associated with pancreatic disease, are
known to present in several respects marked differences from those usually manifested in cases of
diabetes unconnected with aderangement ofthe pancreatic functions, the onset ofpancreatic diabetes
being usually exceedingly sudden ...
It was also, according to Harley, rapidly fatal. He emphasized that in pancreatic diabetes
"even the casual observer" would note that the faeces contained undigested food and
floated in an oily liquid which, on cooling, hardened into a dirty yellowish grease.69
In fact, the diagnosis of pancreatic disease posed major problems. Claude Bernard had
shown the importance of the secretion of the pancreas for digestion of proteins, fats and
carbohydrates and in a few cases ofextensive disease ofthe pancreas clinical observers had
noted that the stools were fatty and contained many muscle fibres.70 Hence the conclusion
that in pancreatic disease there was poorabsorption offat andnitrogen.7' However, in 1887
Friedrich Muller showed that fatty stools occurred in jaundice and claimed that in
pancreatic disease without icterus there was no disturbance of fat and nitrogen
assimilation.72 Coming from such an eminent authority, this carried great weight. Until the
introduction of the first pancreatic function test, Hermann Sahli's glutoid capsule, in
1897,73 diagnosis ofpancreatic disease depended on the bulk ofthe stools and presence of
fat globules and undigested muscle fibres.
The success of thyroid treatment had led to high hopes of a cure for diabetes and on 7
January 1893, Dr R Mansell-Jones suggested that "pancreatic juice, administered either
immediately before or after meals, should be given a fair trial in diabetes, as this disease
appears in most cases to be due to disease ordisordered function ofthis gland".74 This was
69 Vaughan Harley, 'Remarks on two cases of
pancreatic diabetes: the one exceptionally acute, the
other markedly chronic', Br med. J., 1892, i: 9-11.
One was a 23-year-old medical student who at post-
mortem had an atrophied pancreas containing one
large and several small abcesses and the other a 64-
year-old man with cancer ofthe pancreas. At the
time Vaughan Harley was working in Leipzig but
later became Professor ofPathology at University
College, London. He contributed a 6-page article to
the 1896 MedicalAnnual on pancreatic diabetes.
That the subject was highly topical is suggested by
the fact that the section on diabetes in general (by
Saundby) is only 2'/2 pages.
70 This phenomenon was first noted in the 1870s
and became known as creatorrhoea. It was the basis
of Schmidt's BeefCube Test (1900) in which the
patient swallowed small cubes ofbeefhardened in
alcohol and wrapped in silk gauze to aid their
identification in the faeces. It was thought that
nuclei could only be digested by pancreatic
"nuclases" so that their recognition in the cubes
proved pancreatic insufficiency. One commentator
wrote in 1913 that "An indeterminate result is very
common and the process offinding the muscle
fibres in the stools is neither easy nor inviting".
A F S Sladden, 'Critical review: the diagnosis of
pancreatic disease', Q. J. Med., o.s., 1913-14, 7:
455-83.
71 J H Pratt, 'The functional diagnosis of
pancreatic disease', Am. J. med. Sci., 1912, 143:
313-33. This and Sladden's article (op. cit., note 70
above) review the history ofpancreatic function
tests. Both state that there is probably no other organ
whose physiological importance is combined with
such a low level ofclinical knowledge
72 F Muller, 'Untersuchungen uber Icterus',
Zeitsch,PJr Klin. Med., 1887, 12: 45. Friedrich von
Muller (1858-1941) was one ofthe most eminent
German clinicians before World War I.
73 Gelatine capsules containing salol were
hardened in formalin to make them resistant to
gastric digestion but susceptible to pancreatic juice.
Salol was excreted in the urine as salicyluric acid
and recognized by the violet colour when ferric
chloride was added. By 1912, according to Pratt (op.
cit., note 71 above), "the test has few friends".
74 R Mansell-Jones, Letter, Br med J., 1893, i: 50.
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done by various practitioners during the next five months, with a number of inconclusive
but generally negative case reports. Hector Mackenzie75 gave liquor pancreaticus76 to two
patients who felt better and less tired. Neville Wood, Clinical Assistant at the Victoria
Hospital for Children, treated patients aged 13 and 24 with commercially available
pancreatic extracts (zymin and pancreatin pills),77 and Hale White published two more
cases of young people who were given raw fresh sheep's pancreas and, when this was
ineffective, injections of liquor pancreaticus subcutaneously night and morning.78 Further
essentially negative single case reports were published by Sibley ofa 39-year-old patient,79
Marshall of a 56-year-old patient,80 and Wills of a 45-year-old patient.81 Hale White and
Wills observed their patients in hospital for six to twelve weeks and published extensive
tables ofthe urine volume, specific gravity and sugar content. Hale White doubted iffresh
pancreas by mouth or liquor pancreaticus subcutaneously was of any benefit; neither
influenced the quantity of urine or its specific gravity but, he noted, "perhaps they
decreased the amount ofsugar passed and very slightly increased the weight and feeling of
strength". Similar experiments were carried out on the Continent; in 1892 A Capparelli
injected a saline extract offresh pancreas into the abdominal cavity ofa pancreatectomized
dog but, although there was less glycosuria, the experiment was criticized on the ground
that the pancreatectomy had been incomplete. In 1893 Jules Comby injected guinea pigs'
pancreatic juice hypodermically for five days into a 25-year-old man with severe diabetes
without any benefit, although the injections were well tolerated.82 In Turin F Battistini
injected extracts of pancreatic juice into the abdomen of two patients. Both felt better but
the experiments were discontinued because ofpyrexia and abscess formation.83
75 H W G Mackenzie, 'The treatment ofdiabetes
mellitus by means ofpancreatic juice', Br med. J.,
1893, i: 63-4. Sir Hector Mackenzie (1856-1920)
was Assistant Physician at St Thomas's Hospital
and became a full physician in 1900.
76 Liquor pancreaticus was made by treating one
part ofpig's pancreas with a mixture ofone part
rectified spirit and three of water (W Hale White,
Materia medica, pharmacy, pharmacology and
therapeutics, London, J & A Churchill, 1897, p.
605). Its main use was for peptonizing milk.
Benger's liquor pancreaticus was a solution of
pancreatic enzymes in alcohol recommended for
various forms ofdyspepsia or to predigest foods
before they were eaten (W Whitla, Elements of
pharmacy, materia medica and therapeutics,
London, Bailliere, Tindall and Cox, 1910, pp.
429-30. The use ofpancreatic enzymes by mouth
was regarded as "problematical" by most
pharmacologists, since they were known to be
destroyed by acid.
77 Neville Wood, 'The treatment ofdiabetes by
pancreatic extracts', Br med. J., 1893, i: 64.
78 W Hale White, 'On the treatment ofdiabetes
mellitus by feeding on raw pancreas and by the
subcutaneous injection of liquor pancreaticus', Br
med. J., 1893, i: 452-3. At this time Hale White
(1857-1949) was a Lecturer in Materia Medica and
Assistant Physician at Guy's Hospital. He was later
knighted. The clinical clerk for one ofthese cases
was F G (later Sir Frederick Gowland) Hopkins.
79 W K Sibley, 'On the treatment ofdiabetes
mellitus by feeding on raw pancreas', Br med. J.,
1893, i: 579-80.
80 A L Marshall, 'Treatment ofdiabetes by
pancreatic extract', Br med. J., 1893, i: 743.
Marshall used a proprietary preparation, Savory &
Moore's pancreatin "One cupola (grv) three times a
day, one hour after meals".
81 W A Wills, 'A case ofdiabetes treated by the
administration ofraw pancreas', Br med. J., 1893, i:
1265-6. William Alfred Wills (1862-1924) became
Assistant Physician with charge ofoutpatients at the
Westminster Hospital in 1893.
82 K H Leichest, 'Insulin precursors-a
historical sketch: the first attempts at treating
diabetes with pancreatic extracts', in Diabetes: its
medical and cultural history, ed. D von Engelhardt,
Berlin and Heidelberg, Springer Verlag, 1989,
pp. 397-404.
83 Epitome ofcurrent medical literature', Br
med. J., 1893, ii: 71 (abstract no. 359). F Battistini,
'Due casi di diabete mellito curati con iniezioni di
estratto pancreatico', Gior d. r Accad. di med. di
Torino, 1893, 3.s, 41: 290-300.
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In 1894 McNamara, Assistant Surgeon at the Harrow Road Dispensary, suggested that
fresh uncooked pancreatic extract should be given per rectum and if necessary through the
rectal veins. The rationale was that the "mysterious sugar restraining element acted directly
on the liver and would be destroyed in the general circulation". Since these ideas had
occurred to him, McNamara had not had a case of diabetes, but he offered them to
"members of the profession who might be more fortunately circumstanced".84 In 1894
Watson Williams treated a 15-year-old boy in the Bristol Royal Infirmary sequentially with
minced pancreas and liquid extract by mouth, his own extract hypodermically, Brown-
Sequard's pancreatic extract and finally orchitic fluid from a young bull. This took a month
and, when it had clearly failed, Williams persuaded a surgeon to implant three pieces ofthe
sheep's pancreas into the boy's subcutaneous tissue. Unfortunately the operation
precipitated diabetic coma and the boy died three days later.85
A much delayed account was that of Cowles who in 1911 reported a case he had treated
in 1897. A 26-year-old man, developed diabetes in 1894 and by 1897 was expected to die
at any time; as a last resort he ate up to six raw calves' pancreata every day and, although
his urine never became sugar free, he felt well enough to go back to work. Two months after
starting the treatment he ate some stale pancreas, vomited and refused to eat any more.
After another three months he developed an enormous carbuncle and died. Cowles tried the
treatment in other cases without benefit, and attributed success in this one to the enormous
amount of raw pancreas this patient was able to eat. He did not publish the case earlier
because "the results seemed so simple and natural".86
It would be wrong to give the impression that in the decade after Minkowski's discovery,
the pancreatic theory of the origin of diabetes was pre-eminent. In fact, it was generally
agreed that diabetes was heterogeneous and John Rose Bradford, Professor of Materia
Medica at University College Hospital, pointed out that:
the disease diabetes is itself of mixed origin. Further, the lesions causing the malady may not only be
functional or organic in nature, but even if organic they may be diverse, in one case a lesion of the
liver and in another a lesion of the pancreas causing the disease.87
Bradford regarded the hepatic origin of diabetes as fully established by laboratory
experiments, although he doubted the therapeutic value of liver extracts.88 In his book on
organotherapy, Batty Shaw noted that most work on hepatic extracts had been done by the
French, who "not content with the use of various oils derived from the cod, seal etc., have
sought to show that other substances can be extracted from the liver capable ofproducing
favourable effects in various pathological conditions".89 Gilbert and Lereboulet subdivided
84 J McNamara, 'Suggestions for the treatment 86 W N Cowles, 'A case ofdiabetes treated by
ofpancreatic diabetes', Br. med. J., 1894, ii: 126. By feeding ofcalves' pancreas', Boston med. surg. J.,
1910 McNamara was Medical Officer of the UK 1911, 164: 921-2.
Commercial Travel Benefit Society. Why he was 87 J R Bradford, 'Recent experimental
interested in diabetes is unclear. contributions to the pathology ofdiabetes', The
85 P Watson Williams, 'Notes on diabetes treated Practitioner, 1900, n.s. 12: 131. See note 44 above.
with extract and by grafts of sheep's pancreas', Br 88 'The present day treatment ofdiabetes', The
med. J., 1894, ii: 1303-4. Cammidge mentions a case Practitioner, 1900, n.s. 12: 152-60.
reported by J W Allan in which a cat's pancreas was 89 Batty Shaw, op. cit., note 55 above, p. 67.
used, but it "died and sloughed out". P J Cammidge, Harold Batty Shaw (1866-1936) was at the time
Glycosuria and allied conditions, London, Edward Assistant Physician at University College Hospital.
Arnold, 1913, p. 332.
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diabetes into mild glycosuria due to chronic insufficiency ofthe liver (anhepaty) and more
severe cases due to excessive action of the liver (hyperhepaty).90 Gilbert and Carnot gave
liver extract subcutaneously and per rectum; an extract of 150 gm freshly minced pig liver
per rectum was claimed to be ofdiagnostic value; in anhepaty, the liver was stimulated and
glycosuria disappeared while, in hyperhepaty, there was an intensification of glycosuria.
According to Batty Shaw, liver organotherapy for diabetes was never taken seriously in
England.91
How often organic liquids were used forthe treatment ofdiabetes orother illnesses needs
further research but, in the last decade of the nineteenth century, manufacturing chemists
were quick to jump on the bandwagon. By 1894 Ferris & Company of Bristol announced
that they were the sole agents for the organic fluids prepared by Messrs Chaix & Remy,
Paris, according to the processes of Dr Brown-Sequard and others. As well as pancreatic
fluid "for the treatment ofall cases ofglycosuria" they could supply orchitic, renal, supra-
renal, spleen and medulla ofbone, grey matterofbrain and muscular fluid. These were sold
in sealed tubes each sufficient for one injection, and cost 17s.6d. perdozen (Figure 1).92 By
1896 Burroughs Wellcome were offering organic principles of animal original in
"tabloids". Noting that there was an enormous demand among the profession, they warned
that the keeping powers of liquid extracts were uncertain and they were "generally
inoperative and often harmful". Instead, Wellcome offered tabloids of thyroid gland,
thymus, orchitic substance, pituitary body, ceribrinin, ovarian substance, pineal gland, bone
medulla, suprarenal capsules and splenic substance. Tabloids of orchitic substance were
indicated for "nymphomania, epilepsy, hysteria, neurasthenia and perverted sexual habits",
while suprarenal tabloids were "claimed to be very energetic in their action on the renal and
vascular systems".93 Much was made in these advertisements ofthe potency of suprarenal
substance. It was clearly implied that other organic fluids were equally potent.94
In the five years after the dramatic announcements of Minkowski and Brown-Sequard,
attempts to cure diabetes by pancreas feeding and injecting were carried out very much on
an ad hoc basis by clinicians and, as we have seen, manufacturing chemists marketed
extracts ofvirtually all bodily organs. The interest ofEnglish physiologists in what came to
be known as "internal secretions" can probably be traced to the fortituous discovery ofthe
vasopressor effects of adrenal extract in 1894. The Harrogate physician George Oliver
persuaded Edward Schilfer, Professor of Physiology at University College London, to
inject his home-made suprarenal extract into a dog whose blood pressure was being
90 A Gilbert, P Lereboulet 'Les opotherapies patients', J. Am. med. Ass., 1930, 94: 1811-16.
dans le diabete sucrd', Gaz. Hebdom. de Me'd., 1901, 9' A Gilbert, P Camot, 'Essais d'opotherapie
81: 961, cited by Batty Shaw, op. cit., note 55 hepatique', Semaine Me'dicale, 1896, 16: 580; idem,
above, p. 57. In the same year these authors 'Actions des extraits hepatique sur la glycosurie
described the formn ofhyperbilirubinaemia which is experimentale', Semaine Me'dicale, 1896, 16: 513;
now known as Gilbert's disease. In the late 1920s idem, 'De l'opotherapie hepatiques dans le diabete
there was a resurgence of interest in the effect of sucre', Semaine Medicale, 1897, 17: 189. Batty
liver extracts in diabetes. See Harry Blotner and W Shaw, op. cit., note 55 above, p. 55.
P Murphy, 'The effect of liver on the blood sugar 92 MedicalAnnual, Bristol, John Wright and
level', J. Am. med. Ass., 1929, 92: 1332; Harry Sons, 1894, p. 799.
Blotner, 'The effect of liver on the blood sugar in 93 MedicalAnnual, Bristol, John Wright and
diabetic patients', J. Am. Dietetic Ass., 1929, 5: 102; Sons, 1896, advertisements, p. xxix.
and Harry Blotner and William P Murphy, 'Effect of 94 Ibid., 1896, p. 675.
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Figure 1: Advertisement for organic fluids from the Medical Annual 1894. For diabetes a combination of
pancreatic and orchitic fluid is recommended.
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measured. It is said that Schafer "stood amazed to see the mercury mounting in the arterial
manometer till the recording float was lifted almost out of the distal limb".95 What
impressed Schafer and his contemporaries was the tiny dose necessary to produce
physiological effects; as little as 5/2 mg of dried suprarenal produced a maximal effect on
the heart and arteries of a 10 kg dog.96 In an address to the annual meeting of the British
Medical Association in London in August 1895, Schafer endorsed Brown-Sequard's view
that all tissues and organs produced an internal secretion and concluded:
These internal secretions have to be definitely reckoned with by the physician, while at the same time
the therapeutist will be able to avail himselfofthe active principles they contain, and in certain cases
to use extracts of internally secreting glands in place of the hitherto more commonly employed
vegetable medicaments. That the subject has a vast future there can be no doubt ...
One piece of evidence he relied on greatly was Minkowski's pancreatectomy experiment,
Schafer continued:
The only fact that appears certain in connection with the manner in which the pancreas prevents
excessive production of sugar within the body is that this effect must be produced by the formation
ofsome material, secreted internally by the gland andprobably by the internal vascularislets, andthat
this internally secreted material profoundly modifies the carbohydrate metabolism of the tissues.97
Schafer's view that the internal vascular islands or islands of Langerhans produced the
hypothetical internal secretion was, in an age still dominated by traditional morbid
anatomy, not widely accepted.98 In fact, the absence of lesions in the pancreas in ordinary
post-mortems led many to deny the connection of the pancreas with diabetes. As Bunge
remarked, "Up to the present, pathological anatomy has led to no conclusion. Post-mortem
examination of the bodies of diabetics proves that there is not a single organ that does not
occasionally show anatomical changes; on the other hand, there is not a single organ that
does not frequently appear normal".99 Nevertheless, at the turn of the century, Opie in the
USA and Sobolev in Russia did describe pathological changes confined to the islets. In
1899, Leonid V Sobolev (1876-1919) became fascinated by the islets, which he thought
could only be structures for internal secretion because they lacked ducts and were
intimately related to capillaries. He suggested that they were functionally and anatomically
independent structures which controlled carbohydrate metabolism. In thirteen of fifteen
cases of diabetes he found quantative changes; in four, no islands were present, while in
nine there were fewer than normal. He drew the conclusion that:
By ligating the pancreatic duct we now have a means of isolating the islands anatomically and of
studying their chemical properties freed from the digestive ferments. This anatomic isolation will
95 Sir Henry Dale, 'Accident and opportunism in 98 The islets were described by Paul Langerhans,
medical research', Br med. J., 1948, ii: 451-5. See then aged 22, in his doctoral thesis in 1869. Their
also Borell, 'Organotherapy', op. cit., note 4 above. function was not recognized until 1893 when
96 E A Schaifer (ed.), Textbook ofphysiology, 2 Laguesse suggested that they might produce the
vols, Edinburgh and London, Young J Pentland, hypothetical internal secretion of the pancreas.
1898, vol. 1, p. 957. 99 G Bunge, Text-book ofphysiological and
97 E A Schafer, 'Address in physiology on pathological chemistry, trans. Florence A Starling,
internal secretions', delivered at the annual meeting London, Kegan, Paul, Trench, Trubner, 1902, p.
of the British Medical Association, London, 2 386.
August 1895, Lancet, 1895, ii: 321-4.
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permit the testing, in a rational way, ofan organotherapy for diabetes ... We arejustified in the hope
that in the near future the question will be decided whether or not this method of approach will
succeed in relieving the ills ofthe diabetic patient.
Convinced that it would not be possible to obtain enough tissue by duct ligation, Sobolev
even suggested the use of newborn calves in which the islands are well developed in
comparison to the acinar tissue.10° Eugene Opie's interest in the islets was stimulated
during his student days at Johns Hopkins, when his teacher William Welch told him to
"Find out all you can about these islands of Langerhans".'0' In papers published in 1901
Opie proposed that the islands were secretory organs rather than modified or under-
developed acinar cells.'02
At the turn of the century many clinicians believed in a form of human pancreatic
diabetes analogous to that produced by pancreatectomy in dogs. In the fifth edition of his
textbook Osler included a three-quarter-page section, 'The pancreas in diabetes'; in it he
concluded that the pancreas, like the liver, had a double secretion and that the source ofthe
antidiabetic principle was the islands of Langerhans. He backed this up with autopsy
findings of his Johns Hopkins colleague Opie in one of his patients, a 24-year-old woman
in whom the glandular tissue was normal but the islets were represented by sharply
circumscribed hyaline structures.103 Tentatively, he divided cases ofdiabetes into lipogenic
(the glycosuria of stout people), neurotic and pancreatic, but admitted that distinguishing
them was difficult. Neither Osler nor the authors of other majortextbooks104 recommended
pancreatic extracts and pharmacologists were scornful of attempts at organotherapy. In the
first edition of his textbook in 1899, Arthur Cushny warned that advance in
organotherapeutics was not to be expected from the indiscriminate use ofgland extracts in
every sort of disease. Such progress as had been made, he asserted, was due to "careful
observation and experiment and not to haphazard use of the hypodermic syringe".'05
Further Attempts to isolate the anti-diabetic Principle of the Pancreas: 1900-1914
At a meeting of the Society of Biology in Paris in December 1922 Eugene Gley asked
that an envelope deposited by him in 1905 be opened and read. In this, he described how
in 1900-1901 he had prepared extracts from pancreata degenerated by duct occlusion and
found that when injected they decreased the glycosuria of completely depancreatized dogs
and alleviated diabetic symptoms. Gley's report indicated his intention to isolate the active
100 My account of Sobolev is taken from an interstitial pancreatitis to the islands of Langerhans
appreciation by Cornelia van Beek, 'Leonid V and to diabetes mellitus', J. exp. Med., 1901, 5: 397,
Sobolev, 1876-1919', Diabetes, 1958, 7: 245-8. His idem, 'The relation of diabetes mellitus to lesions of
thesis was published in 1901 and a condensed the pancreas; hyaline degeneration of the islands of
version of 33 pages appeared in German a year later. Langerhans', J. exp. Med., 1901, 5: 527.
Ill health forced him to resign from his post in the 103 Osler, op. cit., note 25 above, 5th ed., 1903,
Department of Pathology in 1912 and in 1919 he p. 326.
died in a mental hospital. 104 For example F Taylor, The practice of
101 Peyton Rous, 'An inquiry into certain aspects medicine, London, J & A Churchill, 1898.
of Eugene L Opie', Arch. Path., 1942, 34: 1-6. For a 105 Cushny, op. cit., note 61 above, pp. 690-1.
synopsis of Opie's life, see Joseph Hughes, 'Eugene This paragraph appears unchanged in all subsequent
L Opie', Diabetes, 1958, 7: 496-9. editions of the book up to the 6th in 1918.
102 E L Opie, 'On the relation of chronic
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anti-diabetic principle, study its action and see ifthe extracts could be used on man, either
subcutaneously or by mouth. For unknown reasons he did not pursue his ideas.106
In 1903 John Rennie reported in the Quarterly Journal ofMicroscopical Science that the
islets ofteleostean fishes were independent ofthe pancreas proper and many species had a
relatively large principal islet. Working in Aberdeen with Thomas Fraser, Rennie was able
to get large supplies of islet tissue from the fishmarket to give to diabetic patients.'07 The
first, an 18-year-old boy, was treated in November 1902 with an average of0.57 grams of
islet tissue daily by mouth. No real benefit resulted and he died in March 1903. Four more
patients were treated, usually with islets macerated in a mortar, digested for some time at
40°C and then taken by mouth. However, between 9 and 14 October 1904 the third patient,
a 44-year-old man, was given a filtered extract by hypodermic injection. The dose was
usually one-fifth ofa gram but this route was abandoned because ofthe reaction it caused.
The only indication of this was that on the fourth day "his circulation was disturbed. His
evening pulse 104". His urine volume and excretion of sugar were unaffected, and Rennie
and Fraser concluded either that they had not given enough islet substance (a maximum of
4 grams a day for one week) or that the metabolism ofcold blooded fish might differ from
that of mammals. Twenty years later, a year after the discovery of insulin, the Lancet
suggested that Rennie might have been successful had there been some simple method of
estimating the blood sugar.'08 The standard Bertrand method, used up to about 1910,
required 50-100 ccs ofblood which was defibrinated by stirring in an evaporating dish as
it was drawn from the vein. The blood was then heated and a deproteinized filtrate
prepared. Then followed preparation of a cuprous oxide precipitate which was washed and
weighed.109 A method described by the Professor ofPhysiology in Dundee in 1896 took at
least one hour for each determination and demanded meticulous laboratory technique. It
would have been totally impractical for use in patients even ifhospitals had had a chemical
laboratory. As endpoints, clinicians were therefore obliged to use subjective feelings ofthe
patient, weight and the volume ofurine and its sugar content.
In 1906 Georg Zuelzer, a young physician in Berlin, took pancreata, tied off the ducts,
removed the whole organ, squeezed outthejuice, precipitated the proteins with alcohol, and
administered the alcohol-free extract subcutaneously and intravenously."' Over the next
three years he treated eight patients and, in his published report, concluded that his extract
eliminated the excretion of sugar and ketone bodies without any change in the diet.112
Zuelzer's extract, patented as Acomatol, was tested in Minkowski's clinic by Forschbach
106 Gley's communication is described in 'Action
des extraits de Pancr6as sclerose sur des chiens
diabetiques', Societe de Biologie. Comptes Rendus,
87 (Dec. 1922). Accounts in English can be found in
J P Hoet, 'Gustave Edouard Laguesse: his
demonstration of the significance ofthe islands of
Langerhans', Diabetes, 1953, 2: 323, and Bliss op.
cit., note 1 above, pp. 170-1. Depositing sealed
envelopes at learned societies was common in
France as a way ofestablishing priority for a
discovery.
107 J Rennie and T Fraser, 'The islets of
Langerhans in relation to diabetes', Biochem. J.,
1907, 2: 7-19.
108 'Biochemistry and medicine', Lancet, 1923, ii:
791-2, p. 791.
109 W C Stadie, 'Obituary of Henry Rawle
Geyelin', Diabetes, 1957, 6: 291-2.
110 E Waymouth Reid, 'A method for the
estimation of sugar in blood', J. Physiol. Lond.,
1896, 20: 316-21.
1ll Bliss, op. cit., note I above, pp. 29-33; K H
Mellinghoff, Georg Ludwig Zuelzers, Beitrag zur
Insulinforschung, Dusseldorf, Michael Triltsch, 1971.
112 G Zuelzer, 'Uber versuche einer specifischen
fermentherapie des Diabetes', Z. Exp. Path. Ther.,
1908, 5: 307-18. When Zuelzer's first paper
appeared the editor stated in a footnote that he had
withheld publication for three years at the request of
the author. Apparently Zuelzer asked for this delay
in the hope of being able to report a non-toxic
extract (Pratt, op. cit., note 2 above, p. 286).
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on three dogs and three humans but, although confirming that it suppressed glycosuria, he
felt that the side effects, especially fever, were so severe that it would be impossible to use
therapeutically.113 Zuelzer continued his experiments until 1914 when he was called into
the army. In retrospect, one might conclude that his failure to produce a therapeutically
active extract was mainly due to lack of a powerful backer whereas the failure of Ernest
Scott was due to a powerful professor who thwarted him.
Scott was areticent man and what we know abouthis experiments in Chicago in 1910-11
comes from a paperby his pupil Dickinson Richards, the 1956 Nobel Laureate in Medicine
or Physiology114 and a privately printed book by Scott's second wife.115 Scott went to the
University ofChicago in 1908 to work with the newly appointed Professor of Physiology,
Anton J Carlson (1875-1956), who appears to have been uninterested rather than actively
antagonistic to his work.116 Scott believed that the digestive enzymes of the pancreas
destroyed its internal secretion117 and first ligated the ducts to atrophy the acinar tissue.
When this failed he extracted fresh pancreas with sand and warm alcohol. His extract
produced a significant drop in glycosuria and in the dextrose:nitrogen ratio in three out of
four dogs. The conclusions he drew in his thesis were:
1st, there is an internal secretion from the pancreas controlling the sugar metabolism.
2nd, by proper methods this secretion may be extracted and still retain its activity.
3rd, this secretion is easily destroyed by oxidation or by the action of the digestive enzymes of the
pancreas.
4th, the secretion is insoluble or nearly so, in strong alcohol but is readily soluble in acidulated water.
5th, the failure of previous workers to procure satisfactory results was due to their not preventing
oxidation or the action ofthe digestive enzymes.118
As Richards pointed out, these conclusions were clear, unequivocal and, in the light of
Banting and Best's work, correct.119 Unfortunately, by the time Scott's paper was
published, a sentence had been inserted warning that "It does notfollow that these effects
aredue to the internal secretion ofthepancreas in the extract" (myitalics).120 What Scott's
wife described as "that damning sentence" was almost certainly inserted by Carlson, who
in 1917 wrote:
The endeavour to determine how absence of the pancreas causes diabetes is practically a record of
repeated failures. The leading idea in all this work has been the internal secretion theory ... [but] ...
113 J Forschbach, 'Versuche zur Behandlung des
Diabetes Mellitus mit dem Zuelzerschen
Pancreashormone', Deutsch. Med. Wschr., 1909, 35:
2053.
114 D W Richards, 'The effect ofpancreas extract
on depancreatised dogs: Ernest L Scott's thesis of
1911', Perspect. Biol. Med., 1966, 10: 84-5.
115 A H Scott, Great Scott: Ernest Lyman Scott's
work with insulin in 1911, Bogota, New Jersey, Scott
Publishing Co., 1972.
116 Scott, according to his wife (A H Scott, ibid.,
p. 6), said that Carlson had wanted him to work on a
different problem but "I had come with my own
problem, to find out something about diabetes which
killed young men in their prime". Mrs Scott
compares Carlson ("a recent Swedish immigrant")
unfavourably with her husband ("a fourth-generation
Ohio farm boy").
117 The beliefthat the pancreas contained a
"powerful ferment" which would destroy the
hypothetical internal secretion was a widespread
misapprehension. As early as 1875 Heidenhain had
shown that extracts of fresh pancreas have no
proteolytic activity and in 1902 Delezenne found
that trypsinogen is only activated when it comes in
contact with the succus entericus (Batty Shaw, op.
cit., note 55 above, pp. 173).
118 Scott's thesis (No. T-10553) was submitted to
the University ofChicago in 1911 and obtained by
Richards in 1965.
119 Richards, op. cit., note 114 above, p. 85.
120 E L Scott, 'On the influence of intravenous
injections of an extract of the pancreas on
experimental pancreatic diabetes', Am. J. Physiol.,
1912, 24: 306.
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the possibility that the work of the pancreas in maintaining normal sugar metabolism consists of
detoxification processes must always be kept in view. The fact that even temporary glycosuria is not
induced in normal animals by diabetic blood does not render the detoxification hypothesis untenable.121
After moving to Kansas, Scott continued his interest in the internal secretion of the
pancreas and in 1912 visited J R Macleod (then Professor of Physiology at the Western
Reserve University, Cleveland) who was "not interested, he just shrugged it off'.122
Although he later shared the Nobel Prize for the discovery ofinsulin, Macleod's reaction is
not surprising because as late as 1921 he was, like Carlson, ambivalent about the role ofthe
pancreas, writing:
the removal of some hormone necessary for proper sugar metabolism is, however, by no means the
only way in which the results can be explained, for we can assume that the pancreas owes its influence
over sugar metabolism to some change occurring in the composition of the blood as this circulates
through the gland-a change which is dependent on the integrity of the gland and not on any one
enzyme or hormone which it produces.
To Macleod, either view was tenable and the only experiment which would be decisive was
to see ifreplacing the hypothetical hormone restored normality. He concluded that:
there is no evidence that the blood of a normal animal, even when it is from the pancreatic vein,
contains an internal secretion that can restore to a diabetic animal any of its lost power to utilise
carbohydrate.123
Undoubtedly, this message came across loud and clear to Scott but in retrospect he
attributed his failure to being forced to use as his endpoint Lusk's D:N ratio124 rather than
blood sugar which, since, it needed 20 ccs for each measurement, for a thirty-six hour
experiment virtually involved exsanguinating even large cats.125 In a letter to the Journal
ofthe American Medical Association in 1923 Scott disclaimed any part in the isolation of
insulin but suggested that the discovery of the curative power of "insulin" had been open
from January 1912 to anyone who cared to repeat and extend his work.126
How the hypothetical hormone worked was of course a matter of conjecture but one
suggestion, associated particularly with Otto Cohnheim, was that it might activate a ferment
121 A L Carlson, 'The endocrine pancreas and
its contribution to the sex life of women', Surg.
Gynaec. Obstet., 1917, 25: 283-93. This curiously
titled paper is, apart from the final 1'/2 pages, a
review of attempts to resolve the enigma of
pancreatic diabetes. Commenting on his own
pancreatectomy experiments in pregnant dogs,
Carlson said, "This absence of diabetes may be
due either to the pancreas hormones of the fetus
passing into the mother's blood or to some
detoxicating action on the part of the fetal
pancreas".
122 Scott, op. cit., note 115 above, p. 28.
123 J J R Macleod, Physiology and biochemistry
in modern medicine, 3rd ed., London, Henry
Kimpton, 1921, p. 714.
124 The D:N ratio or relation between urinary
excretion of dextrose and nitrogen was introduced in
1904 by Graham Lusk (1886-1932), who concluded
that in the severest diabetic the ratio was 3.65:1. By
this was meant that on an exclusively fat:protein diet
3.65 grams of dextrose appeared in the urine for I
gram of nitrogen. In other words, 60 per cent of the
protein burned by the body appears in the urine as
sugar; see E P Joslin, The treatment ofdiabetes
mellitus, Philadelphia and New York, Lea and
Febiger, 1917, pp. 131-2. Joslin did not find the
D:N ratio helpful and pointed out that after fasting
the D:N ratio completely disappeared when the urine
became sugar free. "It is thus", said Joslin, "hard to
understand how a patient one day fails to burn the
protein of an ox and on the next day burns his own
body protein with ease".
125 E L Scott, 'The relation of pancreatic extract
to the sugar of the blood', Proc. Soc. exp. Med.
Biol., 1913, 10: 101-3.
126 E L Scott, 'Priority in discovery of a
substance derived from the pancreas, active in
carbohydrate metabolism', J. Am. med. Ass., 1923,
81: 1303-4.
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in muscle. Cohnheim reported that the combination of pancreas and muscle extract had a
marked glycolytic action and, as this occurred in a cell free fluid, it must, he thought,
indicate a glycolytic ferment in the muscle which was activated by the internal secretion of
the pancreas.127 In 1911 Henry Sewall, Professor ofMedicine in the University ofDenver,
reported his own experiments with muscle and pancreatic extracts by mouth.128 Four
patients, all beyond middle age, were treated with what Sewall admitted was "essentially
beef soup" and three appeared to derive some benefit. Then in December 1909 he treated a
7-year-old girl first with a simple beef infusion (juice by mouth) and then with a mixed
beef-pancreas preparation made by soaking "about six ounces of ground fresh beef
pancreas in one quart of water acidulated with 1 dram of dilute hydrochloric acid". He
established to his own satisfaction that a sequence of beef followed by pancreatic juice
could abolish glycosuria for up to three weeks and greatly increase carbohydrate tolerance.
Unfortunately, fresh pancreas was difficult to obtain and most unpalatable, so Sewall tried
a proprietary pancreatic preparation, "Holadin", and a glycerine extract of fresh pancreas.
The results were disappointing, as were further attempts to treat the girl with beef and
pancreas juice. Sewall wondered whether frequent administration of beefjuice had led to
formation of an antienzyme but found it hard to reconcile such an explanation with the
physiology ofcarnivorous animals.
Interestingly, it was only when Sewall's paper was in press that his attention was drawn
to "the brilliant lectures delivered by T Lauder Brunton nearly forty years ago".'29 Sewall
referred only to the workofMervynCrofton,130 Lecturerin Special Pathology atUniversity
College, Dublin, who, believing that pancreatic extracts were destroyed by acid in the
stomach, gave a 13-year-old diabetic girl insoluble capsules containing a proprietary
pancreatic product, Fairchild's Holadin.131 This was followed by a "remarkable reduction
in the quantity of urine" for the two months the capsules were given. Then, thinking the
pancreas had recovered sufficiently to stand an additional stimulus, Crofton gave atablet of
secretin three times aday to "help the damaged pancreas do better work". Crofton's interest
was vaccine therapy and, according to him, Almroth Wright had suggested that the
pancreatic lesion might be due to "an acute or subacute microbial inflammation which may
subside and leave behind a greater or less degree of fibrosis."132 On this basis Crofton
127 0 Cohnheim, 'Ueber
Kohlehydratverbrennung. 2. Mitteiling. Die
aktivierende Substanz des Pankreas', Zrschr. f
Physiol. Chem., 1904, 42: 401-9.
128 H Sewall, 'Is there a specific treatment for
diabetes mellitus?' Am. J. med. Sci., 1911, 142:
313-28.
129 Brunton, op. cit., note 26 above, p. 223.
130 William Mervyn Crofton studied medicine at
the Royal University in Dublin where a lectureship
in special pathology was created for him. He later
became an immensely successful private practitioner
in London. His son describes him as a man ofgreat
ability and originality who had too much self-
confidence. "He only had to think of an interesting
new theory and it became correct".
131 W M Crofton, 'Pancreatic secretion in the
treatment ofdiabetes', Lancet, 1909, i: 607-9,
p. 608. Holadin is described in the 1913 Medical
Annual (p. 223) as an extract of pancreas from
which all the proteins and external ferments have
been removed.
132 For example, W M Crofton, 'Some cases of
vaccine therapy', Br med. J., 1908, ii: 877, in which
he suggested that the ordinary practitioner could
manage well without measuring the opsonic index.
Vaccine therapy had a tremendous vogue at this
time, mainly as a result of the work and
entrepreneurial activities of Almroth Wright at St
Mary's Hospital Medical School. The previous year
Wright had given a very long address to the Royal
Society of Medicine on 'Vaccine therapy: its
administration, value, and limitations' (Lancet,
1910, ii: 863-74). See also Michael Worboys,
'Vaccine therapy and laboratory medicine in
Edwardian Britain' in Medical innovations in
historicalperspective, ed. J V Pickstone,
Basingstoke, Macmillan, 1992, ch. 5:
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suggested that the ideal treatment for acute cases would be a specific serum or for more
chronic cases a vaccine. When he put forward his ideas at a meeting ofthe Royal Academy
ofMedicine in Ireland in 1911 he received a hostile and sceptical reception.133
In 1912 Murlin and Kramer in New York had the idea of combining duodenal mucosa
and pancreas and extracting the two togetherin the hope that secretin might be an adjuvant.
When their extract was given to a diabetic patient subcutaneously it diminished the
excretion of sugar. In March 1913 they made a new extract which completely eliminated
glycosuria in adepancreatized dog buttheirprofessorconvinced them that this was because
the kidneys had been damaged by too much alkali.134 In 1914 Raulston and Woodyatt tried
to treat diabetes with blood transfusion, without success.135
On the eve ofthe First World War the average doctor could have read a huge variety of
conflicting accounts about the cause of diabetes and the relevance of the pancreatectomy
experiments of the previous twenty years. The London physicians Garrod136 and Hale
White'37 inclined to the polyglandulardoctrine ofthe Vienna School in which diabetes was
thought to be due to a loss ofbalance between the thyroid, pituitary and chromaffin system
on the one hand and the pancreas on the other. Garrod concluded that:
Many organs take part in theregulation ofcarbohydrate metabolism ... The displacement ofone prop
may endanger the equilibrium of the whole fabric . . . We are justified in regarding the normal
metabolic level as maintained by the balance ofa number ofmutually controlling forces ... While it
is true that in some cases of diabetes the nervous system is evidently at fault, and that in others the
thyroid, the pituitary or the pancreas is the seat ofthe disease, in the great majority ofcases which we
encounter in practice we can find no indication of the underlying lesion on which the metabolic
derangement depends.
Nevertheless, others were sure that there must be a human equivalent ofthe type ofdiabetes
produced by pancreatectomy in animals and that this was caused by absence of an internal
secretion. In his 1913 book, Artur Biedl wrote that all the known facts about pancreatic
diabetes pointed unequivocally to suppression ofan internal secretion which normally played
a decisive role in carbohydrate metabolism, although he noted that "the brilliant results
expected of organotherapy have been conspicuously absent in pancreatic diabetes".138 The
author of another contemporary monograph on internal secretions, Wilhelm Falta was also
certain thattheinsularapparatusproduced ahormone which wascarriedtothe liverin venous
blood. He described a patient fulfilling all the conditions of a physiological experiment-a
man with obstructive jaundice, steatorrhoea and gross hydrops of the gallbladder (due to
carcinomaofthepancreas) whohadfive 100gramglucose tolerance tests withoutdeveloping
glycosuria. To Falta this proved that the internal and external secretory elements of the
pancreas were independent and his explanation ofthe failure to isolate the intemal secretion
was that, unlike that ofthe thyroid, it was not stored.139
133 'Royal Academy of Medicine in Ireland: Garrod (1857-1936) introduced the concept of
section ofmedicine', Lancet, 1911, i: 1009-10. inborn errors as a result ofhis studies of
134 J R Murlin and B Kramer, 'A quest for the alkaptonuria in 1899.
anti-diabetic hormone 1913-1916', J. Hist. Med., 137 W Hale White, 'An address on glycosura',
1956,11: 288-98. Lancet, 1914, i: 367-73.
135 B D Raulston and R T Woodyatt, 'Blood 138 Biedl, op. cit., note 47 above, p. 423.
transfusion in diabetes mellitus', J. Am. med. Ass., 139 W Falta, The ductless glandular diseases,
1914, 62: 996-1000. trans. M K Myers, Philadelphia, P Blakiston's Sons,
136 A E Garrod, 'Lettsomian Lectures on 1915, p. 501. Wilhelm Falta (1875-1950) was
Glycosuria', Lancet, 1912, i: 483-8. Archibald assistant to Carl von Noorden. See note 142 below.
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Even those who believed in an intemal secretion were depressed about the possibility of
isolating it. According to Frederick Allen140 the reasons were: (i) the complete
disappointment from organotherapy, (ii) repeated failures to find pancreatic lesions in
diabetic necropsies, and (iii) the differences that were more and more insisted on between
human diabetes and that following pancreatectomy in dogs.'4' The result, according to
Allen, was "a period when few persons were willing to affirm that diabetes is regularly and
fundamentally a pancreatic disorder". In a 1915 review article von Noorden discussed the
evidence (which in his view was overwhelming) that the source of the hormone which
promoted carbohydrate metabolism was the islets ofLangerhans, and concluded:
I have advocated the point ofview that in every case ofreal diabetes, there is a functional breakdown
of the pancreas. Since then, after von Mering and Minkowski had demonstrated this supposition by
the discovery of experimental pancreatic diabetes, nearly all modem investigators have come to the
same conclusion, some earlier, some later ... the intensity ofdiabetes is inversely proportional to the
total quantity of Langerhans islands present in good functioning condition.142
The therapeutic conclusion drawn by von Noorden was the same as that reached by Allen
in the USA143 and George Graham in England;'44 food, and particularly carbohydrate,
stressed the ailing islands of Langerhans and led to a downward spiral of increasing
glandular fatigue. The solution was to give the diabetic as little carbohydrate as possible.
The results ofstarvation treatment appear to have been so relatively satisfactory, at least to
some clinicians, as to push into the background the search for a cure. In 1915 Eliot P
Joslin145 wrote eulogistically that the advance in treatment during the past year had been
greater than any since Rollo's time'46 and that "at one stroke the patient is delivered from
medicines, patent or otherwise, sham kinds oftreatment, gluten breads and in 99 cases out
of a 100 of alkalis". Most English physicians were equally enthusiastic, although after the
introduction of insulin they were readier to admit how awful the starvation treatment had
really been. For example in 1927 Hugh Maclean, Professor of Medicine at St Thomas's
Hospital, wrote:
140 F M Allen, 'Investigative and scientific phases
of the diabetic question; their probable relations to
practical problems ofclinical medicine', J. Am.
med. Ass., 1916, 66: 1525-32. Frederick Madison
Allen (1876-1964) worked at the Rockefeller
Institute and in 1913 published Studies concerning
glycosuria and diabetes, Boston, W M Leonard,
1913.
141 As late as 1921 J J R Macleod claimed that
diabetes in the pancreatectomized dog was
unaccompanied by any of the classical symptoms
seen in the clinical condition. Macleod, op. cit., note
122 above, p. 710.
142 C von Noorden, 'The pancreas', The
Practitioner, 1915, Jan-June, 221-46. Carl H von
Noorden (1858-1944) was famous for his oatmeal
diet for the treatment of diabetes. His best known
book was Diabetes and its treatment, the 1st edition
of which came out in 1895 and the 8th in 1927.
143 F M Allen, E Stillman and R Fitz, Total
dietary regulation in the treatment ofdiabetes, New
York, The Rockefeller Institute for Medical
Research, Monograph No. 11, 1919.
144 G Graham, 'The Goulstonian lectures on
glycaemia and glycosuria', Lancet, 1921, i:
1059-65.
145 E P Joslin, 'Present day treatment and
prognosis in diabetes', Am. J. med. Sci., 1915, 150:
485-96. E P Joslin (1869-1962) was believed
during his career to have seen over 50,000 diabetic
patients. The first edition of his famous textbook,
The treatment ofdiabetes mellitus, was published in
1916. See obituary notice Br med. J., 1962, i:
729-30.
146 In 1797 John Rollo, an Edinburgh physician,
advocated an animal diet including such items as
"fat and rancid old meats", the end result ofwhich
was a reduction in carbohydrate and calorie intake.
See Alexander Marble, 'John Rollo', Diabetes,
1956, 5: 325-7.
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In many cases the diabetic treatment was so severe that the patients could not be induced to continue
with it. Some ofthem quite frankly stated that they preferred death to the physical agony which they
endured.147
It was presumably the scepticism of some clinicians about the starvation "cure" which led
to continuing attempts to isolate the internal secretion.
In 1915 Israel Kleiner at the Rockefeller Institute, New York, reported that, when
intravenous glucose was mixed with an emulsion ofpancreas, diabetic animals handled the
sugar normally, whereas without, disposal of glucose was extremely slow.148 In 1919
Kleiner published the results of intravenous injection of his extract in sixteen
depancreatized dogs. In most there was a substantial reduction in blood sugar between
60-90 minutes after injection. In arepresentative experiment (LP72a) a blood sugar of 331
mg/dl fell to 140 at the end of the 78 minute injection period and was still low 90 minutes
later. Submaxillary gland extract was ineffective, as were spleen and muscle extracts.
Kleiner concluded that the temporary effect of his extract in dogs might be duplicated in
man and might be useful in emergencies. He also noted that it was simple to make and did
nothave any toxic consequences, buthe worried thatthe effect mightbe species specific.149
Others do not appear to have shared this concern, presumably because extract of animal
thyroid was effective in man.
Work very similar to that of Banting and Best was carried out by the Romanian
physiologist and physician Nicolas Paulesco (1869-1931). Paulesco's interest in diabetes
began when he worked with Lancereaux in Paris at the turn of the century when he had
begun work to isolate and study the internal secretion ofthe pancreas.'50 This lapsed until
1916, when he found that an aqueous extract injected into a diabetic dog gave immediate,
iftemporary, reliefofsymptoms. His work was interrupted by the warbut when he resumed
in 1920 he showed convincingly that his extract lowered the blood sugar in both diabetic
and normal dogs.'51 In his first experiment he injected the extract into the externaljugular
vein and over one hour the blood sugar fell from 140 to 26 mg% (7.7 to 1.4 mmoL/l) and
the dog died of hypoglycaemia. When he gave the extract subcutaneously there was too
much local irritation to consider using it in human beings.
How widely was Pancreatic Organotherapy used?
Between 1910 and 1921 clinicians and physiologists were unanimous that attempts to
cure severe diabetes by feeding or injecting pancreatic extracts had failed. Nevertheless,
there is evidence that these treatments were often used as a desperate last resort. Cobb, in a
book on organotherapy for general practitioners, recommended pancreas extracts because:
147 H Maclean, 'The results of insulin therapy in Kleiner's contract at the Rockefeller Institute was
diabetes mellitus', Br med. J., 1927, ii: 1015-19, terminated by F M Allen in 1919 on the ground that
p. 1015. there was no future in this sort ofresearch.
148 I S Kleiner, 'Retention in the circulation of 150 N C Paulesco, Expose des titres et travaux
dextrose in normal and depancreatized animals and scientifiques du Dr Paulesco, Paris, 1899.
the effect of an intravenous injection of an emulsion 151 N C Paulesco, 'Recherches sur le role du
of pancreas upon this retention', Proc. Natn. Acad. pancreas dans l'assimilation nutritive', Int. Arch.
Sci., 1915, 1: 338-41. Physiol., 1921, 17: 85-109. See also I Murray,
149 I S Kleiner, 'The action of intravenous 'Paulesco and the isolation of Insulin', J. Hist. Med.
injections ofpancreas emulsions in experimental Allied Sci., 1971, 26: 149-57.
diabetes', J. biol. Chem., 1919, 40: 153-70.
311Robert Tattersall
It is quite possible that such preparations willturn the scale in favourofthe patient, while ifleft solely
to the conservative method of withholding carbohydrate food it might turn in favour of the disease.
Such therapy as is offered by extracts ofthe pancreas is rational and harmless ... 152
Organo-therapeutic preparations were widely advertised in medical and pharmaceutical
journals. In 1913 the British Organotherapy Company Ltd offered "Modern and scientific
organotherapy products (which) are being extensively prescribed in conditions, having as
their origin, degeneration, metabolic disorder, imperfect functioning, auto-intoxication,
fatigue and exhaustion".153 As well as diabetes, other conditions in which theircompounds
were employed with "exceptional success" were exophthalmic goitre, rheumatoid arthritis,
osteoarthritis, disseminated sclerosis, locomotor ataxia and heart and blood vessel
degeneration. This company was still advertising its products in 1922, when itcould supply
soluble gelatine capsules containing extract of parathyroid, thyroid, thymus, prostatic,
placenta, splenic, pancreatic, gastric mucosa "or any combination thereof'.154 These could
also be supplied in ampoules for hypodermic injection. For glycosuria the company
advertised Eukinase, "a scientifically prepared product containing the entire condensed
duodenaljuice in a dry state and in an active and unalterable form". In 1920 G W Carnrick
Co. offered Trypsogen, described as "an accepted medication in diabetes mellitus and
glycosuric conditions" and said to be a combination of enzymes of the islands of
Langerhans with trypsin, amylopsin, and minute doses of gold and arsenic bromides.155
Seven years earlier this preparation had been recommended in the Medical Annual.156 As
late as 1923 Brown-Sequard's orchitic fluid was still on the scene: John Morgan Richards
and Sons Ltd were importing from Denmark "Spermin Liquidum, DMK", for which the
indications were weakness due to arteriosclerosis, anaemia, diabetes, impotence, tabes
dorsalis and neurasthenia (Figure 2).157
After 1922 pancreatic extracts for diabetes disappear from the advertisements. There are
none in a list ofthirty-four gland products available from Parke Davis & Co.'58 and neither
is pancreatic extract advertised by Duncan, Flockhart &Co.,159 who, like Parke Davis, still
produced combinations ofthyroid, pituitary, ovarian and orchitic tablets ("Tetraglandine").
The justification for pluriglandular preparations was that cells would select the hormones
they needed and discard the rest.160
152 I G Cobb, The organs ofinternal secretion:
their diseases and therapeutic application (a book
forgeneralpractitioners), London, Balliere, Tindall
& Cox, 1917 (1st ed.), 1918 (2nd ed.). Ivo Geikie
Cobb obtained his MRCS, LRCP from St Thomas's
Hospital in 1910 and MD (Brussels) in 1912. As far
as I can tell he never held hospital appointment in
England but his continuing interest in the wilder
shores ofendocrinology is shown by the publication
in 1947 of the 3rd edition ofanother book, The
glands ofdestiny: a study ofthepersonality, an
attempt to prove that personality depends on the mix
of hormones. This was extended to historical
characters, so that "in his prime, Henry VII was an
anterior-pituitary personality but the last few years
ofhis life were marred by the gradual eclipse ofall
his endocrine glands" (p. 9).
153 The British Organotherapy Co. Ltd.,
advertisement, MedicalAnnual, Bristol, John Wright
& Sons, 1913, p. xiii.
154 The British Organotherapy Co. Ltd.,
advertisement, MedicalAnnual, Bristol, John Wright
and Sons, 1922, p. xxxiii.
155 G W Carnrick Co., advertisement, Medical
Annual, Bristol, John Wright and Sons, 1920, p. xiv.
156 MedicalAnnual, Bristol, John Wright and
Sons, 1913, p. 649.
157 John Morgan Richards and Sons Ltd.,
Advertisement, MedicalAnnual, Bristol, John
Wright and Sons, 1923, p. xxix.
158 Parke, Davis & Co. advertisement, ibid., p. xxxv.
159 Duncan, Flockhart & Co., advertisement,
ibid., p. xxii.
160 R G Hoskins, 'Some principles of
endocrinology applicable to organotherapy', J. Am.
med. Ass., 1922, 79: 104-6.
312Pancreatic Organotherapyfor Diabetes, 1889-1921
AL)VERTISEMENTS xxix
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Physiologically Standardised underthe Control of
Prof. Dr. Med.h.c. C. O.JENSEN, Univ. ofCopenhagen.
SUPPLIED IN THREE STRENGTHS:
No. 1. No 2. No. 4.
Each Tablet cont. Each Tablet cont. Each Tablet cont.
100 H.U. 200 H.U. 400 H.U.
INDICATIONS: Myxoedema, Cretinism, Lupus, Psoriasis, Chronic
Eczema, Goitre, Ichthyosis, Enuresis.
ORIGINAL BOTTLES containing 50 and 100 Tablets each.
TABL. GLANDULAE MAMMAE, D.M.K.
1 TABLET = 4'25 FRESH GLAND.
INDICATIONS: HYPOGALACTY, METRORRHAGIA, MENORR-
HAGIA, UTERINE FIBROMATA.
In ORIGINAL BOTTLES containing 100 Tablets.
TABL. OVARIL, D.M.K.
1 TABLET cant. 0-32 gram Dried Glanid-about 2 gra,i fresh Glanid.
INniCATIONS: AMENORRHCA. DYSMENORRHCEA. MENORRHCEA, OLIGOMEN-
ORRHEA. INFANTILISM, ARTIFIAL and NORMAL CLIMACTERIC. CHLOROSIS.
HAEMOPHILIA. In ORIGINAL BOTTLES conitaining 50 anid 100Tablets
SPERMIN LIQUIDUM, D.M.K.
Original Bottles cont. 30 c.c. -=-the Hormones of 2 Testicles.
INDICATIONS: Weakness due to ARTERIOSCLEROSIS. ANjEMIA,
DIABETES. IMPOTENCE. TABES DORSALIS. NEURASTHENIA.
SERA and VACCINES
Prepared in the Laboratories of the famous
DANISH STATE SERUM INSTITUTE, COPENHAGEN
of whlich we are the Sole Distributors. Full Particulars on application.
For Samples anid Literature apply to Sole Agents-
JOHN MORGAN RICHARDS & SONS LTD.
(PHARMACEUTICAL DEPT.)
46 and 47 HOLBORN VIADUCT, LONDON, E.C.1.
TELEPHONES: HCOLBORN 6357 TELEGRAMS: "ADRIATIC (CENT)
1147 LONDON."
Figure 2: Advertisement for organic fluids from the 1923 Medical Annual. In the year that insulin was
marketed in England, testicular fluid is still being advertised for diabetes.
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In a 1922 paper Mackenzie Wallis, Chemical Pathologist at St Bartholomew's Hospital,
claimed to have isolated the internal secretion in 1919 in a form suitable for oral
administration.161 He reported three patients and wrote that those who did best were
between the ages of ten and twenty. One case in which we know it was used in addition to
"various forms ofpancreatic and hepatic extracts, intestinal antiseptics, raw meatjuice and
externally applied oil" was a girl who developed diabetes at the age of four in 1918 and
who, after five and a half years of dietetic treatment, weighed only 28 lbs and could only
tolerate 364 calories a day. She began insulin treatment in October 1923 and was at once
transformed.162 That organotherapy was commonly used as a last resort in desperate cases
up to 1922 is shown by a diabetic patient who wrote to The Times in 1923 saying, "I was a
bit ofa sceptic about insulin. One hears ofa number ofsensational recoveries ... I had tried
two pancreatic preparations and both had failed".163
That pharmaceutical companies continued to advertise organotherapy products for
diabetes and other diseases between 1889 and 1921 suggests a market for their wares. Who
prescribed these products is unknowable, but it was presumably what academic critics
called a credulous profession.164 At a time when doctors faced fierce competition from
irregulars, the pressure for optimistic prescriptions was very high. Organotherapy had
however brought the emerging science of endocrinology into disrepute. A persistent critic
was Swale Vincent. In his 1922 Arris and Gale Lecture he said:
Manufacturing druggists are not the only, nor indeed the chief offenders in this matter. They after all
only push upon the market what they are likely to be able to sell and their prospect of sale depends
on the recommendation of physicians ... The medical press is crowded with articles on the alleged
benefit of organic preparations. The majority of these contributions can only be described as utter
nonsense, and are only fit, as indeed they are frequently destined, to serve the cause of
advertisement.165
One of the most foolish organic preparations, according to Vincent, was a combination of
dessicated pancreas, tonsil and duodenal mucosa to be taken by mouth for diabetes.166 In
retrospect Brown-Sequard was blamed for the drought which descended on clinical
endocrinology for nearly thirty years and it was claimed that any young doctor showing an
interest was naive and gullible or, worse, a gold-digger and quack.'67
A Force ofMagical Activity
The conclusions of the first paper from Toronto on the newly discovered insulin were
that:
(1) blood sugar can be markedly reduced even to the normal values, (2) glycosuria can be abolished,
(3) the acetone bodies can be made to disappear from the urine, (4) the respiratory quotient shows
161 R L Mackenzie Wallis, 'The internal secretion 164 H Cushing, 'Disorders of the pituitary gland',
of the pancreas and its application to the treatment J. Am. med. Ass., 1921, 76: 1721-6.
of diabetes mellitus', Lancet, 1922, ii: 1158-61. 165 Vincent, op. cit., note 45 above, p. 319.
162 W H Passmore, M 0 Raven, 'A case of 166 S Vincent, Internal secretion and the ductless
protracted childhood diabetes mellitus arrested by glands, 3rd ed., London, Edward Arnold, 1924, p.
insulin', Lancet, 1924, i: 896-7. 442.
163 'A patient's point of view', The Times, 7 Aug. 167 H Lisser, 'The Endocrine Society: the first 40
1923. years (1917-1957)', Endocrinology, 1967, 80: 5-28.
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evidence of increased utilisation of carbohydrates, (5) a definite improvement is observed in the
general condition ofthese patients and, in addition, the patients themselves report a subjective sense
ofwellbeing and increased vigour for a period following the administration ofthese preparations.168
These conclusions were amply confirmed by other North American physicians in the
latter half of 1922 and by the British physicians who took part in the Medical Research
Council trial before insulin was released for general use in Britain in April 1923.169 A
patient writing to The Times described it as a force of magical activity'70 and the
pharmacologist Arthur Cushny, who at the turn of the century had complained about
haphazard use of the hypodermic syringe, described the results as brilliant.171 Yet insulin
was expensive'72 and, since it had to be given by injection, inconvenient. Proponents of
oral organotherapy made one last stand. In March 1925 Dr Hollins of Chesterfield wrote
that "the use ofraw fresh gland has yielded such striking results during the 2'/2 years I have
been using it that I think they are worth recording". Hollins claimed that raw pancreas
rendered the urine sugarfree within twenty-four hours, lowered the blood sugarand cleared
ketones from the urine and was free from what he called the grave risks attendant on the
use ofinsulin. Two patients were briefly described but in other cases ("about six in all") the
same excellent results had been obtained and one woman who had been started on insulin
by "an over-zealous house physician" felt less well than she had on raw glands. To the
objection that eating raw gland was loathsome, he retorted "patients inform me that itforms
quite a delicious meal especially when taken with lettuce".173 Two weeks later Dr
Robertson Young wrote to say that in 1895 he had written his Glasgow MD thesis on the
treatment of diabetes by raw pancreas.174 Strangely, his method of administration was
identical to that of Hollins, even to mixing it with lettuce! Dr Dunn of Uppingham
described the effect of raw pancreas on a 21-year-old man and concluded that Dr Hollins'
discovery "is of even greater practical importance than insulin, as it brings the treatment
within the range of the mass of people whereas insulin is only for the few".175 Several
physicians wrote to the British Medical Journal that they had tested raw pancreas under
controlled conditions in hospital, with negative results.176 Dr R D Lawrence tested it on
himself (an insulin-dependent diabetic) and concluded that it was ineffective. In fact, said
Lawrence,
I found raw pancreas so horrible as to prefer a dozen injections a day, ifnecessary, and I am sure that
its continued use would have made me unable to eat much else-thus providing a simple method of
introducing nausea, starvation, and undernutrition into the treatment!177
168 F G Banting, C H Best, J B Collip, W R cost had fallen to 6s.8d. per 100 units and by 1929
Campbell, A A Fletcher, 'Pancreatic extracts in the to 2s.0d. J Liebenau, 'The MRC and the
treatment ofdiabetes mellitus: a preliminary report', pharmaceutical industry: the model of insulin', in J
Can. med. Ass. J., 1922, 12: 141-6, p. 146. Austoker and L Bryder (eds), Historical
169 'Some clinical results ofthe use ofinsulin: a perspectives on the role ofthe MRC, Oxford
report to the Medical Research Council', Br med. University Press, 1989, p. 175.
J., 1923, i: 737-40. 173 T J Hollins, letter, Br med. J., 1925, i: 503-4.
170 'A patient's point ofview', The Times, 7 Aug. 174 R Robertson Young, letter, ibid., p. 632.
1923. 175 William Dunn, letter, ibid., p. 680.
171 Cushny, op. cit., note 61 above, 8th ed., 1924, 176 G A Harrison, letter, ibid., 760-1; P J
p. 542. Cammidge, letter, ibid., p. 805; G Graham, letter,
172 When it first came on the market in April ibid., pp. 859-60.
1923 100 units cost 25 shillings. By April 1924 the 177 R D Lawrence, letter, ibid., p. 1108.
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In conclusion it can be seen that the Lancet's question about the thirty year gap after
Minkowski's work was tendentious. It implied that there was a simple and obvious solution
to the problem of diabetes, if only clinicians and physiologists had not been so blinkered.
In fact, it is quite clear that pathological, physiological, clinical and therapeutic evidence
was seemingly open-ended. Almost any piece ofevidence from any ofthese domains could
be contested with counter-evidence with almost unfailing consistency. Observers regularly
reported failure to replicate results published by others. None ofthis is surprising. In an era
in which standard techniques were only just being created either in the clinic or in the
laboratory, untranslatable practices and knowledge were bound to produce highly
contestable local accounts.
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